These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8070311)

  • 1. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
    Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
    Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs.
    Fasanmade AA; Jusko WJ
    Drug Metab Dispos; 1995 May; 23(5):573-6. PubMed ID: 7587933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
    Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
    Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of sex effect on the pharmacokinetics of primaquine.
    Elmes NJ; Bennett SM; Abdalla H; Carthew TL; Edstein MD
    Am J Trop Med Hyg; 2006 Jun; 74(6):951-2. PubMed ID: 16760502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605).
    Brueckner RP; Fleckenstein L
    Pharm Res; 1991 Dec; 8(12):1505-10. PubMed ID: 1808614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity in rhesus monkeys following administration of the 8-aminoquinoline 8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (WR242511).
    Rockwood G; Duniho S; Briscoe C; Gold M; Armstrong K; Kahler D; Moran A; Baskin S
    J Med Toxicol; 2008 Sep; 4(3):157-66. PubMed ID: 18821488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
    Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
    J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.
    Kim YR; Kuh HJ; Kim MY; Kim YS; Chung WC; Kim SI; Kang MW
    Arch Pharm Res; 2004 May; 27(5):576-80. PubMed ID: 15202566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of a primaquine prodrug without red blood cell membrane destabilization property.
    Davanço MG; Campos ML; Nogueira MA; Campos SL; Marques RV; dos Santos JL; Chin CM; da Fonseca LM; Peccinini RG
    Biopharm Drug Dispos; 2012 Nov; 33(8):437-45. PubMed ID: 22899089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
    Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study on hemolytic toxicity of trifluoroacetoprimaquine and primaquine in rabbits].
    Shi X; Zhan C; Ha S; Yiao J
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(3):218-20. PubMed ID: 7867160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate--JPC2056--in cynomolgus monkeys using an in vivo in vitro model.
    Edstein MD; Kotecka BM; Ager AL; Smith KS; DiTusa CA; Diaz DS; Kyle DE; Schiehser GA; Jacobus DP; Rieckmann KH; O'Neil MT
    J Antimicrob Chemother; 2007 Oct; 60(4):811-8. PubMed ID: 17646199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
    Carmona-Fonseca J; Alvarez G; Maestre A
    Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
    Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine.
    Singh KK; Vingkar SK
    Int J Pharm; 2008 Jan; 347(1-2):136-43. PubMed ID: 17709216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog.
    Anders JC; Chung H; Theoharides AD
    Fundam Appl Toxicol; 1988 Feb; 10(2):270-5. PubMed ID: 3356313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and pharmacokinetics of bulaquine and its major metabolite primaquine in rabbits using an LC-UV method--a pilot study.
    Lal J; Mehrotra N; Gupta RC
    J Pharm Biomed Anal; 2003 Apr; 32(1):141-50. PubMed ID: 12852456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.